Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/28247
Title: | Pharmacokinetic of meglumine antimoniate encapsulated in phosphatidylserine-liposomes in mice model: A candidate formulation for visceral leishmaniasis |
Authors: | BORBOREMA, Samanta Etel Treiger; OSSO JUNIOR, Joao Alberto; TEMPONE, Andre Gustavo; ANDRADE JUNIOR, Heitor Franco de; NASCIMENTO, Nanci do |
Citation: | BIOMEDICINE & PHARMACOTHERAPY, v.103, p.1609-1616, 2018 |
Abstract: | Visceral leishmaniasis (VL) is a fatal parasitic disease caused by the protozoan Leishmania spp. Meglumine antimoniate (MA) is the main treatment and has demonstrated a promising efficacy in a VL-model when encapsulated into negatively charged liposomes. Considering the current concept for the evaluation of pharmacokinetic parameters at early phases of drug discovery, we developed a formulation of MA-encapsulated into phosphatidylserine liposomes (MA-LP) and analyzed the in vitro antileishmanial activity, physicochemical properties, and pharmacokinetic profile in a mice model. The liposomal formulation had an internal mean diameter of 114 nm and a high stability in plasma. MA-LP was 23-fold more in vitro effective against Leishmania infantum-infected macrophages than the free drug, with a selectivity index higher than 220. The pharmacokinetic studies demonstrated that the liposomes increased the uptake of the drug by the liver and spleen and promoted sustained levels. MA-LP was first eliminated through renal excretion, followed by biliary excretion. In the blood, MA-LP followed a biexponential open model. This work emphasizes the importance of liposomes as potential drug delivery systems for visceral leishmaniasis. |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MPT Artigos e Materiais de Revistas Científicas - LIM/49 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_BORBOREMA_Pharmacokinetic_of_meglumine_antimoniate_encapsulated_in_phosphatidylserineliposomes_in_2018.PDF Restricted Access | publishedVersion (English) | 1.1 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.